THE LIVINGSTON GROUP, LLC

Lobbying for INNOVATIVE VACCINE TECHNOLOGIES · Bio tech company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Utah · posted Jan 15, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

FY2026 appropriations for the development of a synthetic vaccine

Budget/Appropriations

FY2026 appropriations for the development of a synthetic vaccine

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.